Cytek Biosciences Inc (CTKB)
Net profit margin
| Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | ||
|---|---|---|---|---|---|---|---|---|---|
| Net income (ttm) | US$ in thousands | -12,148 | -13,933 | -5,851 | -2,165 | 2,484 | -2,399 | -2,605 | 767 |
| Revenue (ttm) | US$ in thousands | 193,014 | 183,117 | 175,594 | 166,060 | 164,036 | 155,086 | 148,985 | 139,234 |
| Net profit margin | -6.29% | -7.61% | -3.33% | -1.30% | 1.51% | -1.55% | -1.75% | 0.55% |
December 31, 2023 calculation
Net profit margin = Net income (ttm) ÷ Revenue (ttm)
= $-12,148K ÷ $193,014K
= -6.29%
Cytek Biosciences Inc's net profit margin has shown fluctuations over the past eight quarters. The company experienced negative net profit margins in the most recent quarters, with the margin ranging from -3.33% to -7.61%. This indicates that the company's profits were inadequate to cover its expenses during these periods. However, it is worth noting that the net profit margin was positive in some previous quarters, ranging from 0.55% to 1.51%, suggesting that the company was able to generate profits exceeding its costs during those periods. Overall, the trend in the net profit margin suggests that Cytek Biosciences Inc has been facing challenges in maintaining profitability consistently.
Peer comparison
Dec 31, 2023